Sortina Pharma develops small-molecule therapies that target sortilin, a key protein involved in cancer and neurodegenerative diseases. By modulating this pathway, they aim to create novel, precise treatments to slow disease progression and improve patient quality of life, advancing innovation in life sciences and precision medicine.